| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 00% | ₹232.85 0% | 720 | - | - |
| - | - | 750 | ₹1.25 0% | 2,3250% |
| 00% | ₹168.95 0% | 800 | ₹0.95 0% | 13,1750% |
| - | - | 820 | ₹1.95 0% | 4,6500% |
| - | - | 830 | ₹1.45 0% | 15,5000% |
| - | - | 840 | ₹2.25 0% | 26,3500% |
| 3,1000% | ₹108 0% | 850 | ₹4.4 8.64% | 35,6500% |
| 3,1000% | ₹101.8 0% | 860 | ₹5.25 0% | 31,0000% |
| 00% | ₹86.5 0% | 870 | ₹6.5 -5.1% | 40,3000% |
| 7,7500% | ₹91 0% | 880 | ₹9.1 4.59% | 2,00,7250% |
| - | - | 890 | ₹11.5 7.98% | 78,2750% |
| 2,29,4000% | ₹57.75 -3.26% | 900 | ₹13.55 1.87% | 3,65,8000% |
| 7750% | ₹66 0% | 910 | ₹17.45 4.49% | 83,7000% |
| 62,0000% | ₹44.95 -2.7% | 920 | ₹20.4 3.81% | 2,22,4250% |
| 41,8500% | ₹39.4 -1.99% | 930 | ₹25.35 5.4% | 57,3500% |
| 1,17,8000% | ₹34.2 -2.56% | 940 | ₹28.9 0.69% | 76,7250% |
| 3,40,2250% | ₹29.9 -3.23% | 950 | ₹35 4.79% | 1,12,3750% |
| 7,83,5250% | ₹25.5 -3.4% | 960 | ₹41.55 5.85% | 1,14,7000% |
| 3,46,4250% | ₹21.7 -3.12% | 970 | ₹46.7 3.09% | 58,1250% |
| 1,55,7750% | ₹18 -5.51% | 980 | ₹53.4 3.48% | 24,8000% |
| 96,1000% | ₹15.5 -3.42% | 990 | ₹50.4 0% | 7,7500% |
| 5,79,7000% | ₹13 -1.51% | 1,000 | ₹66.25 0.68% | 68,9750% |
| 65,1000% | ₹11.1 -3.47% | 1,010 | - | - |
| 1,73,6000% | ₹9.15 -2.65% | 1,020 | ₹70.7 0% | 13,9500% |
| 1,5500% | ₹7.15 0% | 1,030 | - | - |
| 1,61,2000% | ₹6.3 -10% | 1,040 | ₹115 0% | 6,9750% |
| 18,6000% | ₹5.25 -5.4% | 1,050 | - | - |
| 86,0250% | ₹4.5 -3.22% | 1,060 | ₹104 0% | 5,4250% |
| 2,23,9750% | ₹3.2 -5.88% | 1,080 | - | - |
| 15,5000% | ₹2.15 -2.27% | 1,100 | - | - |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
